Embryotoxicity is a form of toxicity that affects the developing embryo. It can be caused by chemical or physical agents, including drugs, environmental toxins, radiation, and certain viruses. The effects of embryotoxicity can range from subtle developmental delays to major malformations and death. In some cases, effects may only be seen later in life. Embryotoxicity occurs when a toxic agent interferes with normal embryonic development in some way. This interference can be through direct cellular damage or through disruption of important processes such as cell proliferation, differentiation, or apoptosis. The effects can range from minor to severe, and the severity of the effects depends on the specific agent, the dose, and the timing of exposure. The most common effects of embryotoxicity are malformations such as cleft lip and palate, neural tube defects, and heart defects. Exposure to certain agents can also cause growth retardation, intellectual disabilities, and even death.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia